ID

25460

Descripción

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Palabras clave

Versiones (3)
  1. 23/8/17 23/8/17 -
  2. 23/8/17 23/8/17 -
  3. 4/9/17 4/9/17 -
Subido en

4 de septiembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

visit 2,3,4,5 & ongoing adverse events starting dose of ropinirole Parkinson's Disease 101468/166

Inglés

visit 2,3,4,5 & ongoing adverse events starting dose of ropinirole Parkinson's Disease 101468/166

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Descripción

patient's initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Descripción

patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
1- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
Descripción

1- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C0439568
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
4- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
Descripción

4- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C0439568
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
12- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
Descripción

12- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C0439568
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
24- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
Descripción

24- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C0439568
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
QUERY FOR ADVERSE EVENTS Study Period Visit 3 (Day 4)
Descripción

QUERY FOR ADVERSE EVENTS Study Period Visit 3 (Day 4)

Alias
UMLS CUI-1
C0877248
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
QUERY FOR ADVERSE EVENTS Study Period Visit 4 (Day 8)
Descripción

QUERY FOR ADVERSE EVENTS Study Period Visit 4 (Day 8)

Alias
UMLS CUI-1
C0877248
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
QUERY FOR ADVERSE EVENTS Study Period Visit 5 (Day 14)
Descripción

QUERY FOR ADVERSE EVENTS Study Period Visit 5 (Day 14)

Alias
UMLS CUI-1
C0877248
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
Descripción

If YES, please record in the Adverse Events section below. Spontaneously reported or observed Adverse Events should be recorded in the Adverse Events section.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
ADVERSE EVENTS Study Period Ongoing
Descripción

ADVERSE EVENTS Study Period Ongoing

Alias
UMLS CUI-1
C0877248
Has the patient had any new and/or continuing adverse events?
Descripción

If "Yes", indicate below.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
ADVERSE EVENT
Descripción

ADVERSE EVENT

Alias
UMLS CUI-1
C0877248
Severity of Adverse Events
Descripción

If serious, set a tickmark in the field below. Otherwise leave it empty.

Tipo de datos

text

Alias
UMLS CUI [1]
C1710066
START DATE and TIME
Descripción

24-hour clock

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2697888
UMLS CUI [2]
C2697889
STOP DATE and TIME
Descripción

if ongoing, please leave blank 24-hour clock

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2697886
UMLS CUI [2,1]
C0877248
UMLS CUI [2,2]
C1522314
INTENSITY
Descripción

intensity of adverse event

Tipo de datos

integer

Alias
UMLS CUI [1]
C1710066
RELATIONSHIP TO DRUG
Descripción

relationship to drug

Tipo de datos

integer

Alias
UMLS CUI [1]
C0277579
ACTION TAKEN WITH TEST DRUG
Descripción

change of medication

Tipo de datos

integer

Alias
UMLS CUI [1]
C0580105
CORRECTIVE THERAPY
Descripción

If "Yes", record on Concomitant Medication form.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
EVENT COURSE
Descripción

If intermittent, record number of episodes.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
OUTCOME
Descripción

outcome of adverse event

Tipo de datos

integer

Alias
UMLS CUI [1]
C1705586
Volver a la parte superior de la página

Similar models

visit 2,3,4,5 & ongoing adverse events starting dose of ropinirole Parkinson's Disease 101468/166

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
Item Group
1- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
C0877248 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
4- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
C0877248 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
12- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
C0877248 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
24- HOUR POST-DOSE QUERY FOR ADVERSE EVENTS Study Period Visit 2 (Day 1)
C0877248 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
QUERY FOR ADVERSE EVENTS Study Period Visit 3 (Day 4)
C0877248 (UMLS CUI-1)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
QUERY FOR ADVERSE EVENTS Study Period Visit 4 (Day 8)
C0877248 (UMLS CUI-1)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
QUERY FOR ADVERSE EVENTS Study Period Visit 5 (Day 14)
C0877248 (UMLS CUI-1)
Item
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
integer
C0877248 (UMLS CUI [1])
adverse event
Code List
Have there been any adverse events observed or elicited by the following direct question to the patient: "Have you felt different in any way since starting the new treatment?"
CL Item
Yes (1)
CL Item
No (2)
Item Group
ADVERSE EVENTS Study Period Ongoing
C0877248 (UMLS CUI-1)
Item
Has the patient had any new and/or continuing adverse events?
integer
C0877248 (UMLS CUI [1])
adverse events
Code List
Has the patient had any new and/or continuing adverse events?
CL Item
Yes (1)
CL Item
No (2)
Item Group
ADVERSE EVENT
C0877248 (UMLS CUI-1)
Item
Severity of Adverse Events
text
C1710066 (UMLS CUI [1])
severity of adverse events
Code List
Severity of Adverse Events
CL Item
Serious (Serious)
start date and time of adverse event
Item
START DATE and TIME
datetime
C2697888 (UMLS CUI [1])
C2697889 (UMLS CUI [2])
stop date and time of adverse event
Item
STOP DATE and TIME
datetime
C2697886 (UMLS CUI [1])
C0877248 (UMLS CUI [2,1])
C1522314 (UMLS CUI [2,2])
Item
INTENSITY
integer
C1710066 (UMLS CUI [1])
intensity of adverse event
Code List
INTENSITY
CL Item
MILD (1)
CL Item
MODERATE (2)
CL Item
SEVERE (3)
Item
RELATIONSHIP TO DRUG
integer
C0277579 (UMLS CUI [1])
relationship to drug
Code List
RELATIONSHIP TO DRUG
CL Item
NOT RELATED (1)
CL Item
UNLIKELY (2)
CL Item
SUSPECTED (reasonable possibility) (3)
CL Item
PROBABE`LE (4)
Item
ACTION TAKEN WITH TEST DRUG
integer
C0580105 (UMLS CUI [1])
change of medication
Code List
ACTION TAKEN WITH TEST DRUG
CL Item
NONE (1)
CL Item
DOSE REDUCED (2)
CL Item
DOSE INCREASED (3)
CL Item
DRUG INTERRUPTED/RESTARTED (4)
CL Item
DRUG STOPPED (5)
Item
CORRECTIVE THERAPY
integer
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
therapeutic procedure due to adverse event
Code List
CORRECTIVE THERAPY
CL Item
Yes (1)
CL Item
No (2)
Item
EVENT COURSE
integer
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
course of adverse event
Code List
EVENT COURSE
CL Item
INTERMITTENT (1)
CL Item
CONSTANT (2)
Item
OUTCOME
integer
C1705586 (UMLS CUI [1])
outcome of adverse event
Code List
OUTCOME
CL Item
RESOLVED (1)
CL Item
ONGOING (2)
CL Item
DIED (3)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial